Consumer Staples · Household Products · US stock · price as of 16 Oct 2026
Key indicators
Price
$94.11
52-week range
$73.22 – $98.15
Market cap
$75.5B
P/E (trailing)
37.3×
EV / EBITDA
21.7×
Free-cash-flow yield
5.1%
Dividend yield
2.2%
Revenue (last 12 months)
$21.0B
Revenue growth (3y a year)
4.3%
Operating margin
14.9%
Return on invested capital
34.4%
Net debt / EBITDA
1.7×
Fair value
Blended fair value$74.88 range $71 – $80
Versus priceFair−20% to fair value
Peer multiples
$72.88
Fundamentals-adjusted multiple
$78.91
10-year DCF (market-scaled)
$72.86
Earnings power value (floor, not blended)
$36.11
Model uncertainty
Medium
X-Ray Score
57/ 100 · High confidence · ahead of 66% of sector peers
Valuation35
Growth61
Profitability78
Financial health54
Dividends51
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
Colgate-Palmolive sells oral care, personal care, home care and pet nutrition products in many countries. Its brands include Colgate toothpaste, Palmolive soaps and dish liquids, and Hill's pet food. Revenue comes from selling these everyday goods to supermarkets, pharmacies, mass retailers, online sellers and veterinary channels. The company relies on brand strength, steady repeat purchases and distribution in both developed and emerging markets.
The company reported revenue of $21.0 billion for the last twelve months. The three-year revenue growth rate is 4.3% a year. Profitability shows an operating margin of 14.9% and a return on invested capital of 34%. Net debt stands at 1.7 times EBITDA. Shareholders receive a dividend, yielding 2.2%.
StocksXray gives Colgate Palmolive Co an X-Ray Score of 57 out of 100 (high confidence), ahead of 66% of the S&P 500 stocks in its sector. Its strongest lens is profitability (78) and its weakest is valuation (35).
Our fair value blend is $74.88 (range $70.60 to $79.55). At $94.11 the stock trades 26% above that blend, so the label is "Fair" with medium model uncertainty. Fair value is a range, not a price target.
XStocksXray
Colgate Palmolive Co (CL)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2021
FY2022
FY2023
FY2024
FY2025
Now
Price
$76.21
$72.06
$74.79
$87.18
$77.61
$94.11
Market cap
$64.6B
$60.4B
$62.0B
$71.8B
$62.9B
$75.5B
P/E
29.9×
33.8×
27.0×
24.8×
29.5×
37.3×
EV / revenue
4.1×
3.8×
3.6×
3.9×
3.4×
3.9×
EV / EBITDA
18.4×
20.0×
15.3×
16.2×
17.7×
21.8×
Price / free cash flow
23.4×
32.5×
20.4×
20.2×
17.3×
19.6×
Free-cash-flow yield
4.3%
3.1%
4.9%
4.9%
5.8%
5.1%
Price / book
106.2×
150.7×
101.8×
338.5×
1,165.7×
319.7×
Dividend yield
2.35%
2.58%
2.55%
2.84%
2.68%
2.23%
Fundamentals checklist ● 7 Good · ● 6 Average · ● 3 Bad · each check graded against the sector
Cash quality
Earnings backed by cash−14.4%Good
Free-cash-flow yield5.1%Average
Risk models
Altman Z score6.6×Good
Piotroski F-Score5 of 9Bad
Growth
EPS growth (3y)7.3%Average
Free-cash-flow growth (3y)25.0%Good
Revenue growth (3y)4.3%Good
Growth consistency80%Average
Balance sheet
Current ratio1.0×Average
Net debt / EBITDA1.7×Good
Interest cover12.3×Average
Valuation
Fair value vs price0.8×Bad
EBIT / EV yield3.8%Bad
Profitability
Return on invested capital34.4%Good
Operating margin14.9%Average
Gross profitability75.7%Good
XStocksXray
Colgate Palmolive Co (CL)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY21
FY22
FY23
FY24
FY25
LTM
Revenue
17,421
17,967
19,457
20,101
20,382
21,046
Gross profit
10,375
10,248
11,326
12,161
12,251
12,717
Operating income
3,332
2,893
3,984
4,268
3,306
3,131
Net income
2,166
1,785
2,300
2,889
2,132
2,037
Diluted EPS ($)
2.55
2.13
2.77
3.51
2.63
2.52
Free cash flow
2,758
1,860
3,040
3,546
3,634
3,858
Gross margin
59.6%
57.0%
58.2%
60.5%
60.1%
60.4%
Operating margin
19.1%
16.1%
20.5%
21.2%
16.2%
14.9%
Net margin
12.4%
9.9%
11.8%
14.4%
10.5%
9.7%
Balance sheet
FY21
FY22
FY23
FY24
FY25
LTM
Total assets
15,040
15,731
16,393
16,046
16,330
16,790
Cash
832
775
966
1,096
1,288
1,370
Total debt
7,206
8,755
8,239
7,941
7,986
7,823
Equity
609
401
609
212
54
236
Dividend per share ($)
1.79
1.86
1.91
2.48
2.08
2.10
Revenue and net income US$ billions: navy revenue, teal net income
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.